Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Disease × Octreotide × Clear all

Sponsor

Conditions

Neuroendocrine Tumors 6 Neoplasms 4 Carcinoid Tumor 4 Carcinoma 3 Vipoma 2 Neoplasm Metastasis 2 Intestinal Obstruction 2 Carcinoma, Islet Cell 2 Somatostatinoma 1 Recurrence 1 Prostatic Neoplasms 1 Primary Inoperable Thymoma 1 Pleural Effusion 1 Peritoneal Neoplasms 1 Malignant Carcinoid Syndrome 1 Lymphangiomyoma 1 Lymphangioleiomyomatosis 1 Insulinoma 1 Glucagonoma 1 Gastro-enteropancreatic neuroendocrine tumor 1 Gastrinoma 1 Diarrhea 1 Chylous Ascites 1 Chylothorax 1 Carcinoma, Neuroendocrine 1 Breast Neoplasms 1 Ascites 1 Adenoma, Islet Cell 1

Interventions

fluciclovine F-18 2 Positron-Emission Tomography 2 Injections 2 ioflupane 1 aflibercept 1 Water 1 Methylene Blue 1 Mammography 1 Drug Delivery Systems 1 Diagnosis, Computer-Assisted 1 Daunorubicin 1 Cytarabine 1 Control Groups 1 CPX-351 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡